|Title||Serum levels of type II secretory phospholipase A2 and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study.|
|Publication Type||Journal Article|
|Year of Publication||2005|
|Authors||S Boekholdt, M, Keller, TT, Wareham, NJ, Luben, R, Bingham, SA, Day, NE, Sandhu, MS, J Jukema, W, Kastelein, JJP, C Hack, E, Khaw, K-T|
|Journal||Arterioscler Thromb Vasc Biol|
|Date Published||2005 Apr|
|Keywords||Aged, Biological Markers, Case-Control Studies, Coronary Artery Disease, Female, Follow-Up Studies, Great Britain, Group II Phospholipases A2, Humans, Male, Middle Aged, Phospholipases A, Phospholipases A2, Prospective Studies, Risk Factors, Sex Distribution|
OBJECTIVES: To study the prospective relationship between serum levels of type II secretory phospholipase A2 (sPLA2) and the risk of future coronary artery disease (CAD) in apparently healthy men and women.
METHODS AND RESULTS: We conducted a prospective nested case-control study among apparently healthy men and women aged 45 to 79 years. Cases (n=1105) were people in whom fatal or nonfatal CAD developed during follow-up. Controls (n=2209) were matched by age, sex, and enrollment time. sPLA2 levels were significantly higher in cases than controls (9.5 ng/mL; interquartile range [IQR], 6.4 to 14.8 versus 8.3 ng/mL; IQR, 5.8 to 12.6; P
CONCLUSIONS: Elevated levels of sPLA2 were associated with an increased risk of future CAD in apparently healthy individuals. The magnitude of the association was similar to that observed between CRP and CAD risk, and both associations were independent.
|Alternate Journal||Arterioscler. Thromb. Vasc. Biol.|